EN IT

ABBV — AbbVie, Inc. | Setup 20-24 Jul 2026

ABBV
AbbVie, Inc.
Technical analysis updated on: 2026-07-25 · [ 20-24 Jul 2026 ] - Copyright AiTrading67.com
📅 Earnings · Jul 31, 2026 · in 6d
Stock · US
Inside composite NTZ, bullish bias · near monthly high
SCORE IQS Lite
66/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 20
Daily Momentum 15
Weekly Ichimoku 19
Daily CMF 6
Delta 6
IQS Lite components · score
STRUCTURE20/30MOMENTUM15/35ICHIMOKU19/19CMF6/6DELTA6/10

IQS Lite analysis - AiTrading67.com · AbbVie, Inc. (ABBV · ISIN US00287Y1091)

Weekly Structure
At 20/30 structure is solid: moving averages aligned and underlying trend intact.
Daily Momentum
At 15/35 momentum is weak: uncertain push and ill-defined direction.
Weekly Ichimoku
At 19/19 Ichimoku is fully bullish: above the cloud with Tenkan and Kijun aligned.
Daily CMF
At 6/6 CMF shows inflows: capital entering and buying pressure.
Delta
At 6/10 the week is slightly positive: close between 0% and +2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
The weekly structure remains strongly bullish with MACD showing strong conviction, free EMA50, and Ichimoku above the bullish cloud—all suggesting resilient medium-term momentum. However, daily MACD weakness (D) and the mature phase (IQS 80) require disciplined, confirmed entry on breakout above 261.10. Setup is interesting if validated by price action.
This week's view by AiTrading67.com
ABBV consolidates within No Trade Zone with weekly MACD in strong bullish and daily ADX showing strong trend, though daily momentum shows bearish fading. Await confirmed breakout above trigger level for long setup activation. Neutral stance pending consolidation resolution.
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn